Israel Englander Edwards Lifesciences Corp Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Millennium Management LLC holds 524,207 shares of EW stock, worth $34.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

524,207

Previous 273,500 91.67%

Holding current value

$34.5 Million

Previous $26.1 Million 85.27%

% of portfolio

0.02%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $5.8 Million - $6.48 Million	68,755 Added 15.1%	524,207 $48.4 Million
Q1 2024 May 15, 2024	BUY	$72.54 - $95.56 $1.07 Million - $1.41 Million	14,760 Added 3.35%	455,452 $43.5 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $65.2 Million - $82.1 Million	-1,056,392 Reduced 70.56%	440,692 $33.6 Million
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $2.6 Million - $3.01 Million	31,912 Added 2.18%	1,497,084 $141 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $228 Million - $259 Million	-3,068,983 Reduced 67.69%	1,465,172 $121 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $152 Million - $195 Million	2,227,180 Added 96.54%	4,534,155 $338 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $186 Million - $243 Million	2,261,902 Added 5018.31%	2,306,975 $191 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $14.7 Million - $21.7 Million	-169,524 Reduced 79.0%	45,073 $4.29 Million
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $5.96 Million - $7.5 Million	58,429 Added 37.41%	214,597 $25.3 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $3.87 Million - $4.75 Million	36,347 Added 30.33%	156,168 $20.2 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $92 Million - $110 Million	-894,320 Reduced 88.18%	119,821 $13.6 Million
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $45.3 Million - $56.5 Million	539,796 Added 113.8%	1,014,141 $105 Million
Q1 2021 May 17, 2021	SELL	$78.68 - $90.67 $16.8 Million - $19.4 Million	-214,005 Reduced 31.09%	474,345 $39.7 Million
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $45.2 Million - $57.6 Million	631,004 Added 1100.35%	688,350 $62.8 Million
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $34.3 Million - $44.6 Million	-509,838 Reduced 89.89%	57,346 $4.58 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $30.9 Million - $41.3 Million	536,610 Added 1755.12%	567,184 $39.2 Million
Q1 2020 May 14, 2020	SELL	$52.41 - $81.0 $22 Million - $34 Million	-420,182 Reduced 93.22%	30,574 $5.77 Million
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $25.8 Million - $29.5 Million	-359,321 Reduced 44.36%	450,756 $105 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $41.8 Million - $51.3 Million	679,715 Added 521.41%	810,077 $178 Million
Q2 2019 Aug 15, 2019	SELL	$55.74 - $64.41 $10.4 Million - $12.1 Million	-187,269 Reduced 58.96%	130,362 $24.1 Million
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $18.2 Million - $21 Million	-326,048 Reduced 50.65%	317,631 $9.85 Million
Q1 2019 May 14, 2019	BUY	$47.89 - $64.05 $11.9 Million - $15.9 Million	248,683 Added 62.96%	643,679 $123 Million
Q4 2018 Feb 14, 2019	BUY	$46.41 - $56.94 $16.7 Million - $20.5 Million	359,715 Added 1019.57%	394,996 $60.5 Million
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $567,365 - $720,442	12,415 Added 54.29%	35,281 $6.14 Million
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $21.4 Million - $25.9 Million	-504,375 Reduced 95.66%	22,866 $3.33 Million
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $10.8 Million - $13.8 Million	-291,371 Reduced 35.59%	527,241 $73.6 Million
Q4 2017 Feb 14, 2018	SELL	$33.79 - $39.39 $17.6 Million - $20.5 Million	-521,094 Reduced 38.9%	818,612 $92.3 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $48.6 Million - $52 Million	1,339,706	1,339,706 $146 Million

Others Institutions Holding EW

# of Institutions

1,341

Shares Held

467M

Call Options Held

2.45M

Put Options Held

2.56M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.7B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account